Unicycive Therapeutics, Inc. (UNCY) › Shareholders' EquityUnicycive Therapeutics, Inc. (UNCY) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$884.0K2020: -$2.67M2021: $16.48M2022: -$466.0K2023: -$3.81M2024: $7.43M2025: $30.20M$30.20M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$30.20M+306.4%2024$7.43M+295.1%2023-$3.81M-717.4%2022-$466.0K-102.8%2021$16.48M+717.1%2020-$2.67M-202.1%2019-$884.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share